<?xml version="1.0" encoding="utf-8"?>
<rr:ResultsReport>
	<rr:ResultsPayload>
		<FinalReport>
			<Sample>
				<FM_Id>AA -24-00782</FM_Id>
				<SampleId></SampleId>
				<BlockId>M113-10030_(PT24008)</BlockId>
				<TRFNumber></TRFNumber>
				<TestType></TestType>
				<SpecFormat>Ampulla of Vater Type</SpecFormat>
				<ReceivedDate>Feb 06, 2024</ReceivedDate>
			</Sample>
			<PMI>
				<ReportId></ReportId>
				<MRN>***99699</MRN>
				<FullName>邱*換</FullName>
				<FirstName></FirstName>
				<LastName></LastName>
				<SubmittedDiagnosis>Ampulla of Vater adenocarcinoma</SubmittedDiagnosis>
				<Gender>Male</Gender>
				<DOB>Mar **, 1959</DOB>
				<OrderingMD>洪逸平醫師</OrderingMD>
				<OrderingMDId></OrderingMDId>
				<Pathologist></Pathologist>
				<CopiedPhysician1></CopiedPhysician1>
				<MedFacilName>臺北榮總</MedFacilName>
				<MedFacilID></MedFacilID>
				<SpecSite></SpecSite>
				<CollDate></CollDate>
				<ReceivedDate></ReceivedDate>
				<CountryOfOrigin></CountryOfOrigin>
			</PMI>
		</FinalReport>
		<variant-report>
			<short_variants>
				<short_variant>
					<cds_effect>c.248_252dup</cds_effect>
					<depth>166</depth>
					<gene>CDKN2A</gene>
					<percent_reads>30.7%</percent_reads>
					<protein_effect>A85fs</protein_effect>
					<transcript>NM_000077</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.183A&gt;C</cds_effect>
					<depth>1151</depth>
					<gene>KRAS</gene>
					<percent_reads>23.7%</percent_reads>
					<protein_effect>Q61H</protein_effect>
					<transcript>NM_004985</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.742C&gt;T</cds_effect>
					<depth>1075</depth>
					<gene>TP53</gene>
					<percent_reads>27.4%</percent_reads>
					<protein_effect>R248W</protein_effect>
					<transcript>NM_000546</transcript>
				</short_variant>
			</short_variants>
			<copy_number_alterations>
				<copy_number_alteration>
					<copy_number>0</copy_number>
					<gene>NSD1</gene>
					<position>Chr5</position>
					<type>Homozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>CDKN2C</gene>
					<position>Chr1</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>PTEN</gene>
					<position>Chr10</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>CDKN2A</gene>
					<position>Chr9</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>7</copy_number>
					<gene>CRKL, MAPK1</gene>
					<position>Chr22</position>
					<type>Amplification</type>
				</copy_number_alteration>
			</copy_number_alterations>
			<rearrangements>
			</rearrangements>
			<biomarkers>
				<microsatellite_instability>
					<status>Microsatellite stable (MSS)</status>
				</microsatellite_instability>
				<tumor_mutation_burden>
					<score>0.1</score>
				</tumor_mutation_burden>
			</biomarkers>
		</variant-report>
	</rr:ResultsPayload>
</rr:ResultsReport>